• Mădălina-Ioana Meleștean-Bratu Clinical Hospital “Nicolae Malaxa” Bucharest
  • Francesca Frîncu “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania https://orcid.org/0000-0003-2746-6153
  • Claudia Mehedințu University of Medicine and Pharmacy “Carol Davila“ Bucharest https://orcid.org/0000-0001-5231-2848
  • Andreea Carp-Velișcu University of Medicine and Pharmacy “Carol Davila“ Bucharest
  • Alexandru Baroș University of Medicine and Pharmacy “Carol Davila“ Bucharest
  • Monica Cîrstoiu University of Medicine and Pharmacy “Carol Davila“ Bucharest
  • Antoine Edu 1 Clinical Hospital “Nicolae Malaxa” Bucharest 2 University of Medicine and Pharmacy “Carol Davila“ Bucharest
  • Stelian Conci 1Clinical Hospital “Nicolae Malaxa” Bucharest 2 University of Medicine and Pharmacy “Carol Davila“ Bucharest
  • Radu-Nicolae Mateescu 1Clinical Hospital “Nicolae Malaxa” Bucharest 2 University of Medicine and Pharmacy “Carol Davila“ Bucharest
Keywords: placenta previa, placenta percreta, cesarean hysterectomy, vaginal bleeding


Placental disorders, especially Placenta Accreta Spectrum Disorder (PAS) and placenta previa are major risk factors for massive bleeding in obstetrics, being a common cause of maternal morbidity and mortality. When the two of them co-exist, the risk rises exponentially. We present a challenging case of a complete placenta previa and placenta percreta, diagnosed intraoperatively. The patient had a total abdominal hysterectomy and bilateral salpingectomy.


1. E. Norwitz. “Defective implantation and placentation: laying the blueprint for pregnancy complications”. Reprod Biomed Online 2006; 13:591–599
2. T. Weyerstahl, M. Stauber, “Duale Reihe Gynäkologie und Geburtshilfe” 3. Aufl. Stuttgart: Thieme; 2007: 295
3. N. Meriem, “Placenta accreta: Case report presenting obstetric emergency”, Gynecology Obstetrics 2020, World Congress on Gynecology and Obstetrics; October 19-20, 2020
4. Y. Oyelese, JC. Smulian. “Placenta previa, placenta accreta, and vasa previa.”, Obstet Gynecol. 2006 Apr;107(4):927-41. doi: 10.1097/01.AOG.0000207559.15715.98. PMID: 16582134.
5. C. Gloria, P. Salvatore, L. Francesco, et al. “Placenta Accreta Spectrum Disorder in a Patient with Six Previous Caesarean Deliveries: Step by Step Management”. Case Rep Obstet Gynecol. 2021;2021:2105248. Published 2021 Sep 12. doi:10.1155/2021/2105248
6. AA. Okunowo, EO. Ohazurike, FM. Habeebu‑Adeyemi, “Undiagnosed placenta praevia percreta: A rare case report and review of management.” Nigerian Postgrad Med J 2019;26:61-4.
7. P. Dahiya, K.D. Nayar, J S Gulati, K. Dahiya “Placenta Accreta Causing Uterine Rupture in Second Trimester of Pregnancy after in vitro Fertilization; A Case Report.” J Reprod Infertil. 2012;13(1):61-3.
8. K. Benirschke, P. Kaufmann “The Pathology of the Human Placenta - 4th edition.” 2002. New York. Springer.
9. NE. Marshall, R. Fu, JM. Guise “Impact of multiple cesarean deliveries on maternal morbidity: a systematic review”. Am J Obstet Gynecol 2011;205:262.e1–8.
10. N. Tillu, A. Savalia, S. Patwardhan, B. Patil “Placenta percreta with bladder invasion: The armamentarium available in its management.” Urol Ann. 2019;11(3):324-327. doi:10.4103/UA.UA_84_18
11. DA. Miller, JA. Chollet, TM. Goodwin “Clinical risk factors for placenta previa-placenta accreta”. Am J Obstet Gynecol 1997; 177: 210–214
12. DJ. Lyell, AM. Faucett, RJ. Baer, YJ. Blumenfeld, ML. Druzin, YY. El-Sayed, et al. “Maternal serum markers, characteristics and morbidly adherent placenta in women with previa.” J Perinatol 2015;35:570–4.
13. AO. Ersoy, E. Oztas, S. Ozler, E. Ersoy, K. Erkenekli, D. Uygur, et al. “Can venous ProBNP levels predict placenta accreta?”. J Matern Fetal Neonatal Med 2016;29:4020–4
14. J. L. Bailit, W. A Grobman., M. M. Rice., et al. “Morbidly adherent placenta treatments and outcomes.” Obstetrics and Gynecology . 2015;125(3):683–689. doi: 10.1097/AOG.0000000000000680.
15. AA. Shamshirsaz, KA. Fox, B. Salmanian, CR. Diaz-Arrastia, W. Lee, BW. Baker, et al. “Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach.” Am J Obstet Gynecol 2015;212:218.e1–9.
16. EM. Berkley, AZ. Abuhamad “Prenatal diagnosis of placenta accreta: is sonography all we need?” J Ultrasound Med 2013; 32:1345–50
17. SL. Collins, A. Ashcroft, T. Braun, et al. “Proposed for standardized ultrasound descriptions of abnormally invasive placenta (AIP).” Ultrasound Obstet Gynecol 2016;47:271-5
18. E. Jauniaux, SL. Collins, D. Jurkovic, GJ. Burton “Accreta placentation. A systematic review of prenatal ultrasound imaging and grading of villous invasiveness.” Am J Obstet Gynecol 2016;215:712-21.
19. CH. Comstock, JJ Jr .Love, RA. Bronsteen, et al. “Sonographic detection of placenta accreta in the second and third trimesters of pregnancy.” Am J Obstet Gynecol 2004;190:1135-40.
20. SF. Cramer, D. Heller “Placenta accreta and placenta increta: an approach to pathogenesis based on the trophoblastic differentiation pathway.” Pediatr Dev Pathol 2016;19:320-33
21. JC. Shih, JM. Palacios Jaraquemada, YN. Su, et al. “Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques.” Ultrasound Obstet Gynecol 2009;33:193-203.
22. K. Matsuo, CL. Conturie, Lee “Snowman sign: a possible predictor of catastrophic abnormal placentation”. Eur J Obstet Gynecol Reprod Biol 2014;181:341-2.
23. F Chantraine, S. Blacher, S. Berndt, et al. “Abnormal vascular architecture at the placental- maternal interface in placenta increta.” Am J Obstet Gynecol 2012;207:188.e1-9.
24. MM. Chou, ES. Ho, YH. Lee. “Prenatal diagnosis of placenta previa accreta by trans- abdominal color Doppler ultrasound.” Ultrasound Obstet Gynecol 2000;15:28-35.
25. E. Jauniaux, S. Collins, GJ. Burton. “Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging”. Am J Obstet Gynecol. 2018 Jan;218(1):75-87. doi: 10.1016/j.ajog.2017.05.067. Epub 2017 Jun 24. PMID: 28599899.
26. F. D'Antonio.,C. Iacovella, A. Bhide “Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis.” Ultrasound in Obstetrics & Gynecology . 2013;42(5):509–517. doi: 10.1002/uog.13194.
27. I. E.Timor-Tritsch, A. Monteagudo, G. Cali, et al. “Cesarean scar pregnancy and early placenta accreta share common histology.” Ultrasound in Obstetrics & Gynecology . 2014;43(4):383–395. doi: 10.1002/uog.13282.
28. G. Cali, F. Forlani, I. Timor-Tritsch E., J. Palacios-Jaraquemada, G. Minneci, F. D'Antonio “Natural history of cesarean scar pregnancy on prenatal ultrasound: the crossover sign.” Ultrasound in Obstetrics & Gynecology . 2017;50(1):100–104. doi: 10.1002/uog.16216.
29. MW . Rac, JS. Dashe, CE. Wells, E. Moschos, DD. McIntire, DM. Twickler “Ultrasound predictors of placental invasion: the Placenta Accreta Index.” Am J Obstet Gynecol 2015;212:343.e1-7.
30. G. Pagani, G. Cali, G. Acharya, IT. Trisch, J. Palacios-Jaraquemada, A. Familiari, D. Buca, L. Manzoli, ME. Flacco, F. Fanfani, M. Liberati, G. Scambia, F. D'antonio “Diagnostic accuracy of ultrasound in detecting the severity of abnormally invasive placentation: a systematic review and meta-analysis.” Acta Obstet Gynecol Scand. 2018 Jan;97(1):25-37. doi: 10.1111/aogs.13238. Epub 2017 Nov 28. PMID: 28963728.
31. A. Familiari, M. Liberati, P. Lim, G. Pagani, G. Cali, D. Buca, L. Manzoli, ME. Flacco, G. Scambia, F. D'antonio “Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis.” Acta Obstet Gynecol Scand. 2018 May;97(5):507-520. doi: 10.1111/aogs.13258. Epub 2017 Dec 13. PMID: 29136274.
32. FNY. Yu, KY. Leung “Antenatal diagnosis of placenta accreta spectrum (PAS) disorders.” Best Pract Res Clin Obstet Gynaecol. 2021 Apr;72:13-24. doi: 10.1016/j.bpobgyn.2020.06.010. Epub 2020 Jul 15. PMID: 32747328.
33. E. Jauniaux, JC. Kingdom, RM. Silver “A comparison of recent guidelines in the diagnosis and management of placenta accreta spectrum disorders.” Best Pract Res Clin Obstet Gynaecol. 2021 Apr;72:102-116. doi: 10.1016/j.bpobgyn.2020.06.007. Epub 2020 Jun 27. PMID: 32698993.
34. American College of Obstetricians and Gynecologists; Society for Maternal-Fetal Medicine. Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet Gynecol. 2018 Dec;132(6):e259-e275. doi: 10.1097/AOG.0000000000002983. PMID: 30461695.
35. AG. Eller, TF. Porter, P. Soisson, RM. Silver “Optimal management strategies for placenta accreta.” BJOG 2009;116: 648–54.
36. AA. Shamshirsaz, KA. Fox, H. Erfani, SL. Clark, AA. Shamshirsaz, AA. Nassr, et al. “Outcomes of planned compared with urgent deliveries using a multidisciplinary team approach for morbidly adherent placenta.” Obstet Gynecol 2018;131: 234–41.
37. SL. Clark, JP. Phelan, SY. Yeh, SR. Bruce, RH. Paul “Hypogastric artery ligation for obstetric hemorrhage.” Obstet Gynecol 1985;66:353–6.
38. JD. Wright, RM. Silver, C. Bonanno, S. Gaddipati, YS. Lu, LL. Simpson, et al. “Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta”. J Matern Fetal Neonatal Med. 2013;26:1602–9.
39. S. Pala, R. Atilgan, M. Baspinar, EC. Kavak, S. Yavuzkir, A. Akyol, et al. “Comparison of results of Bakri balloon tamponade and caesarean hysterectomy in management of placenta accreta and increta: a retrospective study.” J Obstet Gynaecol 2018;38:194–9
40. L. Sentilhes, C. Ambroselli, G. Kayem, M. Provansal, H. Fernandez, F. Perrotin, et al. “Maternal outcome after conservative treatment of placenta accreta.” Obstet Gynecol 2010; 115:526–34.
41. KA. Fox, AA. Shamshirsaz, D. Carusi, AA. Secord, P. Lee, OM. Turan, et al. “Conservative management of morbidly adherent placenta: expert review." Am J Obstet Gynecol 2015;213:755–60.